Early studies implicated IL-6 and its major effector STAT3 as pro-tumorigenic agents in many cancers, including breast, lung, colon, prostate, ovarian, and hematological cancers as well as melanoma [42]. The gene discussed is IL6; the disease is hematopoietic and lymphoid cell neoplasm.